` The Korean BioChip Society
Go to contents

(사)한국바이오칩학회 The Korean BioChip Society



BT+IT+NTThe Korean BioChip Society

BioChip Journal

Current Issue

Info. Vol.7 - No.3 (2013.09.20)
Title Evaluation of immunoreactivity of in vitro and in vivo models against bacterial synthesized cellulose to be used as a prosthetic biomaterial
Authors Gun-Dong Kim1, Hana Yang1, Hye Rim Park1, Cheung-Seog Park1, Yong Seek Park1 & Seung Eun Lee1
Institutions 1Department of Microbiology, School of Medicine, Kyung Hee University, Hoegi-dong, Dongdaemun-gu, Seoul 130-701, Korea
Abstract Prosthetic biomaterials are required to be non-toxic, non-thrombogenic, and non-immunogenic. Bacterial cellulose (BC) synthesized by Gluconacetobacter xylinus has recently been studied as a biocompatible material due to its unique features such as high purity, crystallinity, biodegradability, and tensile strength as compared to plant cellulose. Although BC has high potential to be used as biomaterial, its toxicity and immunoreactivity have not been properly studied yet. In this report, we investigated the immunoreactivity of BC in vitro in human umbilical vein endothelial cells (HUVECs) and in vivo using BALB/c mice. We report that BC does not induce apoptosis and necrosis in HUVECs and does not stimulate immune response in both HUVECs and BALB/c mice models. These results suggest that BC may be widely used as a biocompatible biomaterial for tissue engineering and biosensors.
Keyword Gluconacetobacter xylinus, Bacterial cellulose (BC), Biomaterials, Immunoreactivity, Human umbilical vein endothelial cells (HUVECs), Lipopolysaccharide(LPS)
PDF File
# 2010년도 발행분 부터는 Springer 의 BioChip Journal 페이지에서 전문을 열람하실 수 있습니다.
# 학회회원 로그인 후 [ Springer BioChip Journal 열람하기 ] 버튼을 클릭하시면 새창으로 열립니다.
→ 전체 목록 보기

Address : Room 804, The Korea Science Technology Center The first building, 22, Teheran-ro 7 Gil, Gangnam-gu, Seoul, Republic of Korea (06130)
TEL : +82-70-7767-9855 , FAX : +82-2-921-9856 , E-MAIL : biochip@biochip.or.kr Copyright © The Korean BioChip Society. All Rights Reserved.